Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · IEX Real-Time Price · USD

5.16

-0.01 (-0.29%)

At close: Jul 2, 2024, 4:00 PM

5.00

-0.16 (-3.01%)

After-hours: Jul 2, 2024, 5:24 PM EDT

Pasithea Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	5	8	19	39
Market Cap Growth	-22.86%	-58.92%	-51.55%	-
Enterprise Value	-7	-9	-14	-14
PE Ratio	-	-0.48	-1.35	-17.82
PS Ratio	-	-	-	2572.20
PB Ratio	0.27	0.33	0.44	0.75
P/FCF Ratio	-0.55	-0.61	-1.56	-12.12
P/OCF Ratio	-0.54	-0.60	-1.58	-12.21
EV/Sales Ratio	-	-	-	-944.38
EV/EBITDA Ratio	0.28	0.56	0.99	6.55
EV/EBIT Ratio	0.27	0.54	0.99	6.55
EV/FCF Ratio	0.32	0.67	1.15	4.45
Debt / Equity Ratio	0.00	0.00	0.01	-
Debt / EBITDA Ratio	0.00	-0.01	-0.04	-
Debt / FCF Ratio	0.00	-0.01	-0.04	-
Quick Ratio	4.87	6.20	17.62	118.42
Current Ratio	5.35	6.34	18.15	119.17
Asset Turnover	0	0	0	0.00
Interest Coverage	-	-	-	-4277.58
Return on Equity (ROE)	-60.70%	-50.50%	-29.20%	-12.60%
Return on Assets (ROA)	-55.50%	-46.60%	-28.00%	-11.40%
Return on Capital (ROIC)	-84.39%	-68.05%	-29.27%	-8.77%
Earnings Yield	-302.81%	-207.04%	-74.25%	-5.61%
FCF Yield	-256.68%	-165.24%	-63.94%	-8.25%
Buyback Yield / Dilution	20.03%	2.83%	-142.65%	-41.29%
Total Shareholder Return	20.03%	2.83%	-142.65%	-41.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).